Cardiotoxicity changes
Showing 1 - 25 of >10,000
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Rochester (Echocardiography, Electronic Health Record
Suspended
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Echocardiography
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 10, 2023
Heart Failure, Cardiotoxicity, Cancer Trial (Cardio-oncology Rehabilitation (CORE), PAI Group (PAI), Exercise Guidelines for
Not yet recruiting
- Heart Failure
- +2 more
- Cardio-oncology Rehabilitation (CORE)
- +2 more
- (no location specified)
Aug 19, 2021
During BReast Adenocarcinoma Therapy to Detect Cardiotoxicity
Recruiting
- Breast Neoplasms
-
Toronto, Ontario, CanadaToronto General Hospital
Nov 2, 2020
Heart Failure, Cardiotoxicity, Cancer Trial (Cardio-oncology Rehabilitation (CORE), Support, Passive Behavioural Support)
Not yet recruiting
- Heart Failure
- +2 more
- Cardio-oncology Rehabilitation (CORE)
- +2 more
- (no location specified)
Oct 18, 2020
Doxorubicin Induced Cardiomyopathy Trial in Cairo (Atorvastatin 40 Mg Oral Tablet, Placebo)
Recruiting
- Doxorubicin Induced Cardiomyopathy
- Atorvastatin 40 Mg Oral Tablet
- Placebo
-
Cairo, EgyptAin Shams University hospitals
Apr 4, 2023
Cardiotoxicity, Tumors, Chemo Effect Trial in São Paulo (Spironolactone, Placebo)
Not yet recruiting
- Cardiotoxicity
- +3 more
- Spironolactone
- Placebo
-
São Paulo, BrazilInstituto do Coração
Aug 16, 2023
Thoracic Cancer, Left Sided Breast Cancer Trial in Dallas ([1-13C]pyruvate along with MRI imaging)
Suspended
- Thoracic Cancer
- Left Sided Breast Cancer
- [1-13C]pyruvate along with MRI imaging
-
Dallas, TexasDepartment of Radiation Oncology; UT Southwestern Medical Center
Nov 14, 2022
Breast Cancer Stage 2 and 3 Trial (Fenofibrate, Placebo, Doxorubicin)
Not yet recruiting
- Breast Cancer Stage 2 and 3
- Fenofibrate
- +3 more
- (no location specified)
Nov 24, 2023
Chemotherapeutic Toxicity, Cardiotoxicity, Heart Failure Trial in Tainan (Prevention therapy, Rescue therapy)
Recruiting
- Chemotherapeutic Toxicity
- +4 more
- Prevention therapy
- Rescue therapy
-
Tainan, TaiwanNational Cheng Kung University Hospital
Jun 6, 2023
Atherosclerosis in Chemotherapy-related Cardiotoxicity
Recruiting
- Cardiotoxicity
- Atherosclerosis
- echocardiography, computed tomography
-
Warsaw, PolandNational Institute of Oncology
Feb 20, 2022
Breast Cancer, Tumor, Breast, Breast Diseases Trial in Poland (Sacubitril-valsartan)
Not yet recruiting
- Breast Cancer
- +12 more
-
Opole, Opolskie, Poland
- +3 more
Jul 15, 2022
Anthracycline Related Cardiotoxicity in Breast Cancer Trial in Lubbock (sulforaphane, Placebo Oral Tablet)
Recruiting
- Anthracycline Related Cardiotoxicity in Breast Cancer
- sulforaphane
- Placebo Oral Tablet
-
Lubbock, TexasTexas Tech University Health Sciences Center
Jul 18, 2022
Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated
Enrolling by invitation
- Cardiotoxicity
- +3 more
- Chemoradiation
-
Birmingham, Alabama
- +6 more
Nov 1, 2022
Cardiotoxicity of Cancer Therapy (CCT)
Enrolling by invitation
- Breast Cancer
- Echocardiography
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Feb 14, 2022
Cardiotoxicity Trial in Warsaw (Empagliflozin 10 MG, Placebo)
Not yet recruiting
- Cardiotoxicity
- Empagliflozin 10 MG
- Placebo
-
Warsaw, Poland
- +1 more
Mar 5, 2022
Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer
Active, not recruiting
- Cancer
- Cardiotoxicity
- Exercise program
-
Hartford, Connecticut
- +1 more
Jan 11, 2022
CARdiac Function Evaluation in Breast Cancer Patients
Completed
- Breast Cancer Female
-
Swansea, Wales, United KingdomSingleton Hospital
Nov 29, 2022
Leukemia, Cardiac Toxicity Trial in Pessac (Echographic analysis of myocardial deformation in 2D strain)
Completed
- Leukemia
- Cardiac Toxicity
- Echographic analysis of myocardial deformation in 2D strain
-
Pessac, FranceService de Cardiologie et Maladies Vasculaires, Hopital du Haut
Feb 8, 2022
New Echocardiographic Indicators in Treatment of Primary
Not yet recruiting
- Multiple Myeloma
- Chemotherapy and/or autologous hematopoietic stem cell transplantation
- (no location specified)
Sep 18, 2023
Defining Late Onset Occult Asymptomatic Cardiotoxicity in
Active, not recruiting
- Cardiovascular Disease
- Cardiac MRI
-
Hartford, ConnecticutConnecticut Children's Medical Center
Jan 11, 2022
Cardiotoxicity in Breast Cancer Patients Treated With Proton or
Enrolling by invitation
- Breast Cancer
- Cardiotoxicity
- Proton vs Photon Radiation
-
Birmingham, Alabama
- +5 more
Mar 4, 2022
Cardiotoxicity, Acute Myeloid Leukemia in Children, Bone Tumor Trial in Cairo (Capoten®)
Recruiting
- Cardiotoxicity
- +2 more
-
Cairo, EgyptChildren's Cancer Hospital Egypt 57357 Cairo, Egypt
Aug 2, 2021
Breast Cancer, Metastatic Breast Cancer, Cancer Therapy-Related Cardiac Dysfunction Trial in Lørenskog (Nicotinamide Riboside,
Not yet recruiting
- Breast Cancer
- +4 more
- Nicotinamide Riboside
- Placebo
-
Lørenskog, Akershus, NorwayAkershus University Hospital
Feb 14, 2023
MyoStrain CMR for the Detection of Cardiotoxicity
Completed
- Cardiotoxicity
- +2 more
- MyoStrain
-
Hamburg, GermanyMarien Krankenhaus GmbH
Jun 22, 2021
Cardiovascular Toxicity: Comprehensive Myocardial and Vascular
Recruiting
- Cardiovascular Diseases
- +7 more
- Cardiovascular magnetic resonance with stress perfusion
- +4 more
-
London, United KingdomSt Bartholomews Hospital
Sep 15, 2023